DIE WIRKUNG VON CYCLOPHOSPHAMID UND EINIGEN DERIVATEN AUF DIE CORTISONINDUKTION DER TYROSIN-AMINOTRANSFERASE IN DER RATTENLEBER. = L'ACTION DU CYCLOPHOSPHAMIDE ET DE QUELQUES DERIVES SUR L'INDUCTION PAR LE CORTISOL DE LA TYROSINE-AMINOTRANSFERASE DANS LE FOIE DU RATKROGER H; GRATZ R.1978; ARZNEIMITTEL-FORSCH.; DEU; DA. 1978; VOL. 28; NO 6; PP. 970-973; ABS. ANGL.; BIBL. 8 REF.Article

Human multilineage progenitor cell sensitivity to 4-hydroperoxycyclophosphamideROWLEY, S. D; COLVIN, O. M; STUART, R. K et al.Experimental hematology. 1985, Vol 13, Num 4, pp 295-298, issn 0301-472XArticle

In vitro effects of 4-hydroperoxycylophosphamide on concanavalin A-induced human suppressor T cellsKLAJMAN, A; DRUCKER, I; MANOR, Y et al.Cancer immunology and immunotherapy. 1984, Vol 18, Num 2, pp 113-117, issn 0340-7004Article

STEREOCHEMISTRY OF ACTIVATED CYCLOPHOSPHAMIDE ANTITUMOR DRUGS: MOLECULAR STRUCTURE OF 4-HYDROPEROXYCYCLOPHOSPHAMIDE.CAMERMAN A; SMITH HW; CAMERMAN N et al.1975; BIOCHEM. BIOPHYS. RES. COMMUNIC.; U.S.A.; DA. 1975; VOL. 65; NO 3; PP. 828-832; BIBL. 14 REF.Article

ELIMINATION OF ACUTE MYELOGENOUS LEUKEMIC CELLS FROM MARROW AND TUMOR SUSPENSIONS IN THE RAT WITH 4-HYDROPEROXYCYCLOPHOSPHAMIDESHARKIS SJ; SANTOS GW; COLVIN M et al.1980; BLOOD; USA; DA. 1980; VOL. 55; NO 3; PP. 521-523; BIBL. 17 REF.Article

RELATIVE SUSCEPTIBILITIES OF T CELL SUBSETS IN VOLVED IN DELAYED-TYPE HYPERSENSITIVITY TO SHEEPS RED BLOOD CELLS TO THE IN VITRO ACTION OF 4-HYDROPEROXYCYCLOPHOSPHAMIDEKAUFMANN SHE; HAHN H; DIAMANTSTEIN T et al.1980; J. IMMUNOL.; ISSN 0022-1767; USA; DA. 1980; VOL. 125; NO 3; PP. 1104-1108; BIBL. 17 REF.Article

RESISTENZTESTUNG MENSCHLICHER TUMOR- UND KNOCHENMARKSZELLEN GEGENUEBER ZYTOSTATIKA. = TEST DE RESISTANCE DES CELLULES MEDULLAIRES ET TUMORALES HUMAINES AUX CYTOSTATIQUESKAUFMANN M; KUBLI F.1978; FORTSCH. D. MED.; DTSCH.; DA. 1978; VOL. 96; NO 15; PP. 823-826; ABS. ANGL.; BIBL. 19 REF.Article

SENSIBILITAETSTESTUNG HISTOLOGISH CHARAKTERISIERTER OVARIAL- UND KORPUSKARZINOME GEGEN 4-HYDROPEROXICYCLOPHOSPHAMID, AMETHOPTERIN, MITOPODOZID UND 4-O-DIMETHYL-1-O-(4,6-O-2-THENYLIDEN-BETA -D-GLUCOPYRANOSYL) EPIPODOPHYLLOTOXIN MIT DER PRIMAERKULTURTECHNICK. = ESSAI DE SENSIBILITE DE CARCINOMES DE L'OVAIRE ET DU CORPS DE L'UTERUS CARACTERISE HISTOLOGIQUEMENT ENVERS L'HYDROPEROXY-4 CYCLOPHOSPHAMIDE, L'AMETHOPTERINE, LE MITOPODOZIDE ET LA O-DIMETHYL-4 O-(4,O 6,O-THENYLIDENE-2 D-GLUCOPYRANOSYL)-EPIPODOPHYLLOTOXINE PAR LA TECHNIQUE DE CULTURE PRIMAIREJANKOWSKI RP; WETZEL V; VAHRSON H et al.1977; STRAHLENTHERAPIE; DTSCH.; DA. 1977; VOL. 153; NO 8; PP. 545-552; ABS. ANGL. FR.; BIBL. 14 REF.Article

In vitro evaluation of cisplatin interaction with doxorubicin or 4-hydroperoxycyclophosphamide against human gynecologic cancer cell linesMIN-JIAN XU; ALBERTS, D. S; LIU, R et al.Cancer chemotherapy and pharmacology. 1989, Vol 25, Num 2, pp 89-94, issn 0344-5704Article

DNA cross-linking and single-strand breaks induced by teratogenic concentrations of 4-hydroperoxycyclosphosphamide and phosphoramide mustard in postimplantation rat embryosLITTLE, S. A; MIRKES, P. E.Cancer research (Baltimore). 1987, Vol 47, Num 20, pp 5421-5426, issn 0008-5472Article

Intrathecal administration of 4-hydroperoxycyclophosphamide in rhesus monkeysARNDT, C. A. S; COLVIN, O. M; BALIS, F. M et al.Cancer research (Baltimore). 1987, Vol 47, Num 22, pp 5932-5934, issn 0008-5472Article

Mutagenic and toxic effects of 4-hydroperoxycyclophosphamide and of 2,4-tetrahydrocyclohexylamine (ASTA-Z-7557) on human lymphocytes cultured in vitroPEROCCO, P; PANE, G; SANTUCCI, M. A et al.Experimental hematology. 1985, Vol 13, Num 10, pp 1014-1017, issn 0301-472XArticle

Antitumor effect and metabolic activation of cyclophosphamide and 4-hydroperoxycyclophosphamide in the human breast carcinoma (MX-1)-nude mouse system = Effet antitumoral et activation métabolique du cyclophosphamide et du 4-hydroperoxycyclophosphamide dans le système tumeur du sein humain MX-1-souris nudeKUBOTA, T; HANATANI, Y; TSUYUKI, K et al.Gann. 1983, Vol 74, Num 3, pp 437-444, issn 0016-450XArticle

CFU-GM content of bone marrow graft correlates with time to hematologic reconstitution following autologous bone marrow transplantation with 4-hydroperoxycyclophosphamide-purged bone marrowROWLEY, S. D; ZUEHLSDORF, M; BRAINE, H. G et al.Blood. 1987, Vol 70, Num 1, pp 271-275, issn 0006-4971Article

Comparative in vitro effects of cyclophosphamide derivatives on murine bone marrow-derived stromal and hemopoietic progenitor cell classesDE JONG, J. P; NIKKELS, P. G. J; BROCKBANK, K. G. M et al.Cancer research (Baltimore). 1985, Vol 45, Num 9, pp 4001-4005, issn 0008-5472Article

In vitro effects of 4-hydroperoxycyclophosphamide on the morphology and function of human peripheral blood mononuclear phagocytic cells (macrophages)JASON, M; ANDREWS, B. S; COLVIN, M et al.Cancer research (Baltimore). 1984, Vol 44, Num 9, pp 3936-3941, issn 0008-5472Article

Effect of Lonidamine on the cytotoxicity of four alkylating agents in vitroROSBE, K. W; BRANN, T. W; HOLDEN, S. A et al.Cancer chemotherapy and pharmacology. 1989, Vol 25, Num 1, pp 32-36, issn 0344-5704Article

Dose-response effects of 4-hydroperoxycyclophosphamide on human T and B cell function in vitroKODO, H; BONAVIDA, B; COLVIN, M et al.International journal of immunopharmacology. 1985, Vol 7, Num 4, pp 555-560, issn 0192-0561Article

Synergism between 4-hydroperoxycyclophosphamide and cisplatin : importance of incubation sequence and measurement of cisplatin accumulationPETERS, R. H; STUART, R. K.Biochemical pharmacology. 1990, Vol 39, Num 3, pp 607-609, issn 0006-2952Article

The growth-inhibitory effect of 4-hydroperoxycyclophosphamide against human non-small cell lung carcinoma is enhanced by low-dose difluoromethylornithineTSAI, D. C; LUK, G. D.Cancer chemotherapy and pharmacology. 1988, Vol 22, Num 1, pp 36-40, issn 0344-5704Article

Comparative cytotoxicity of various drug combinations for human leukemic cells and normal hematopoietic precursorsTAI-TSUNG CHANG; SUBHASH GULATI; TING-CHAO CHOU et al.Cancer research (Baltimore). 1987, Vol 47, Num 1, pp 119-122, issn 0008-5472Article

Prediction of the ability to purge tumor from murine bone marrow using clonogenic assaysJONES, R. J; COLVIN, O. M; SENSENBRENNER, L. L et al.Cancer research (Baltimore). 1988, Vol 48, Num 12, pp 3394-3397, issn 0008-5472Article

SYNTHESIS OF 4-HYDROPEROXY DERIVATIVES OF IFOSFAMIDE AND TROFOSFAMIDE BY DIRECT OZONATION AND PRELIMINARY ANTITUMOR EVALUATION IN VIVO.HOHORST HJ; PETER G; STRUCK RF et al.1976; CANCER RES.; U.S.A.; DA. 1976; VOL. 36; NO 7 PART. 1; PP. 2278-2281; BIBL. 21 REF.Article

Activity of intrathecal 4-hydroperoxycyclophosphamide in a nude rat model of human neoplastic meningitisFUCHS, H. E; ARCHER, G. E; COLVIN, O. M et al.Cancer research (Baltimore). 1990, Vol 50, Num 6, pp 1954-1959, issn 0008-5472Article